Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente ONCOGENE

Tipo Año Título Fuente
Artículo2023N7-methylguanosine methylation of tRNAs regulates survival to stress in cancerONCOGENE
Artículo2022Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1ONCOGENE
Artículo2021Critical requirement of SOS1 RAS-GEF function for mitochondrial dynamics, metabolism, and redox homeostasisONCOGENE
Artículo2021E3 ubiquitin ligase Atrogin-1 mediates adaptive resistance to KIT-targeted inhibition in gastrointestinal stromal tumorONCOGENE
Artículo2021Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcomaONCOGENE
Artículo2019A Sox2-Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cellsONCOGENE
Artículo2016Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumorsONCOGENE
Artículo2016Sos1 disruption impairs cellular proliferation and viability through an increase in mitochondrial oxidative stress in primary MEFsONCOGENE
Artículo2016Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expressionONCOGENE
Artículo2015HMG20A is required for SNAI1-mediated epithelial to mesenchymal transitionONCOGENE
Letter2014The in vivo antitumor activity of cardiac glycosides in mice xenografted with human cancer cells is probably an experimental artifactONCOGENE
Artículo2013WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cellsONCOGENE
Artículo20121q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcomaONCOGENE
Artículo2012p38 alpha limits the contribution of MAP17 to cancer progression in breast tumorsONCOGENE
Revisión2011Histone onco-modificationsONCOGENE
Artículo2005Characterization of VIK-1: a new Vav-interacting Kruppel-like proteinONCOGENE
Artículo2004c-Jun phosphorylation by the human vaccinia-related kinase 1 (VRK1) and its cooperation with the N-terminal kinase of c-Jun (JNK)ONCOGENE
Artículo2002Expression of hpttg proto-oncogene in lymphoid neoplasiasONCOGENE
Artículo2000Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene productONCOGENE
Artículo1999hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasiasONCOGENE
Artículo1998hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTGONCOGENE
Artículo1997Enhanced apoptosis in the thymus of transgenic mice expressing constitutively activated forms of human Rac2GTPaseONCOGENE
Artículo1995The proline-rich region of Vav binds to Grb2 and Grb3-3ONCOGENE
Artículo1994Vav binds to several sh2/sh3 containing proteins in activated lymphocytesONCOGENE